Characteristics of included studies1 and reported mortality and probability of survival at 12 months post-ART initiation by region.

F = female; PY = person years;1Only studies reported mortality measurements at 12 months post-ART initiation were listed. See {table S2} for summaries of papers not listed here [19], [60]–[68];2SSA: Sub-Saharan Africa; Americas: South & Central America, Caribbean; Multi-regional: includes SSA, Asia and the Americas;3Deaths expressed as percent of total population in the study;4Probability of survival was only presented by CD4 cell count level: CD4200: 0.99.5Probability of survival was only presented by CD4 cell count level: CD4150: 0.94.6Probability of survival was only presented by TB status: with TB: 0.42, without TB: 0.82.7Proportion was reported during each calendar year: 2002–'03: 13.0%, 2003–'04: 7.9%, 2004–'05: 5.0%;8Assumed death and loss-to-follow-up were 12 month data since only 12-month assessment was mentioned.9Loss to follow-up was reported but time was not given;10Supplement table 3 was used to obtain data for adults only;11Probabilities were reported in both active (0.94) and passive (0.98) follow-up groups.